Takeda Pharmaceutical Company Limited
Prophylactic or therapeutic agent for delirium
Last updated:
Abstract:
The present invention provides a prophylactic or therapeutic agent for delirium containing compound (I) having melatonin receptor affinity. A compound represented by the formula: ##STR00001## wherein each symbol is as described in the specification, or a salt thereof.
Status:
Grant
Type:
Utility
Filling date:
5 Jan 2017
Issue date:
16 Nov 2021